Command Palette

Search for a command to run...

Clinical Trials · NCT05458856

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Ipsen
Enrollment
147
Start date
Aug 2022
Locations
39 sites, 7 countries
Primary endpoint
Percentage of Participants Who Maintained Castrate Levels of Serum Testosterone During the Study
View Gonadorelin compound reference